Package 11534-192-03
Brand: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Generic: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfatePackage Facts
Identity
Package NDC
11534-192-03
Digits Only
1153419203
Product NDC
11534-192
Description
1000 TABLET in 1 BOTTLE (11534-192-03)
Marketing
Marketing Status
Brand
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Generic
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "86a00bec-51eb-4d73-a945-b1937970b29a", "openfda": {"upc": ["0311534193039", "0311534192032", "0311534191035", "0311534196016", "0311534190038", "0311534196030", "0311534195033"], "unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["541363", "541878", "541892", "577957", "577961", "687043", "1009145"], "spl_set_id": ["ac102599-3a5b-4154-899e-6ff262be7ff7"], "manufacturer_name": ["SUNRISE PHARMACEUTICAL, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (11534-192-01)", "package_ndc": "11534-192-01", "marketing_start_date": "20180704"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (11534-192-03)", "package_ndc": "11534-192-03", "marketing_start_date": "20180704"}], "brand_name": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE", "product_id": "11534-192_86a00bec-51eb-4d73-a945-b1937970b29a", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "11534-192", "dea_schedule": "CII", "generic_name": "dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate", "labeler_name": "SUNRISE PHARMACEUTICAL, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "2.5 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "2.5 mg/1"}], "application_number": "ANDA209799", "marketing_category": "ANDA", "marketing_start_date": "20180704", "listing_expiration_date": "20261231"}